Global Synthetic Biology Market is valued at USD 5.5 Billion in 2019 and expected to reach USD 24.14 Billion by 2026 with the CAGR of 23.53 % over the forecast period. Synthetic biology market is driven by significant advancements in biomedical industry. It has lot of applications in healthcare, agriculture, manufacturing in production of industrial enzymes, bio- chemicals, biofuels etc. Growing investments from private and government in the sector, evolving genetic engineering, cost reductions in DNA sequencing are some of the major factors driving the growth of global Synthetic biology market. In the last 10 years synthetic biology industry has raised over $12.3B in investment. In first quarter of 2019 65 synthetic biology companies have raised $1.9 billion in funding. Major funding was into therapeutics and food industry for bioengineered products. Biosafety concerns and presence of stringent regulatory policies are hindering the growth of market. Developing applications for therapeutics, enzyme product
